Only about half of bacterial species use an asparaginyl-tRNA synthetase (AsnRS) to attach Asn to its cognate tRNA Asn . Other bacteria, including the human pathogen Moraxella catarrhalis, a causative agent of otitis media, lack a gene encoding AsnRS, and form Asn-tRNA Asn by an indirect pathway catalysed by two enzymes: first, a non-discriminating aspartyl-tRNA synthetase (ND-AspRS) catalyses the formation of aspartyl-tRNA Asn (Asp-tRNA Asn ); then, a tRNAdependent amidotransferase (GatCAB) transamidates this 'incorrect' product into Asn-tRNA Asn . As M. catarrhalis has a Gln-tRNA synthetase, its GatCAB functions as an Asp-tRNA Asn amidotransferase. This pathogen rapidly evolved to about 90 % ampicillin resistance worldwide by insertion of a bro-1 b-lactamase gene within the gatCAB operon. Comparison of the GatCAB subunits from bro-1 b-lactamase-positive and bro-negative strains showed that the laterally transferred bro-1 gene, inserted into the gatCAB operon, affected the C-terminal sequence of GatA. The identity between the C-terminal sequences of GatA wt (residues 479-491) and of GatA BRO-1 (residues 479-492) was about 36 %, whereas the rest of the GatA sequence was relatively conserved. The characterization of these two distinct GatCABs as well as the hybrid GatCAB containing GatA(1-478) wt (479-492) BRO-1 and truncated GatCAB enzymes of M. catarrhalis showed that the substitution in GatA wt of residues 479-492 of GatA BRO-1 causes increased specificity for glutamine, and decreased specificity for Asp-tRNA Asn in the transamidation reaction. We conclude that the bro gene insertion has altered the kinetic parameters of Asp-tRNA Asn amidotransferase, and we propose a model for gatA evolution after the insertion of bro-1 at the carboxyl end of gatA.